Request Deal Involvement
Bayer completed the acquisition of Vividion Therapeutics from Versant Ventures for $2bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Credit Suisse
legal advisors
Baker McKenzie
financial advisors
Centerview Partners
legal advisors
Cooley
or
Principals
bidder
BAYER AG
target
VIVIDION THERAPEUTICS
vendor
VERSANT VENTURES
vendor
ALEXANDRIA VENTURE INVESTMENTS
vendor
ALTITUDE LIFE SCIENCE VENTURES
vendor
ARCH VENTURE PARTNERS
vendor
CARDINAL PARTNERS
vendor
MUBADALA VENTURES
vendor
NEXTECH INVEST
vendor
CASDIN CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite